Eli Lilly says FDA delays approval of Alzheimer’s drug in surprise move

Eli Lilly says FDA delays approval of Alzheimer’s drug in surprise move

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Eli Lilly headquarters in Indianapolis, Indiana, US, on Wednesday, May 3, 2023. Eli Lilly & Co.’s shares climbed in early US trading after its experimental drug for Alzheimer’s slowed the progress of the disease in a final-stage trial, paving the way for the company to apply … Read more

Healthy Returns: The launch of breakthrough Alzheimer’s drug Leqembi is off to a slow start

Healthy Returns: The launch of breakthrough Alzheimer’s drug Leqembi is off to a slow start

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Good afternoon! The launch of the closely watched Alzheimer’s drug Leqembi is off to a slow start. Still, demand for the treatment from Biogen and its Japanese partner Eisai is rising. That’s the update the two drugmakers gave Wall Street during their latest quarterly earnings calls earlier … Read more

Biogen revenue and profit shrink on Aduhelm costs, slumping sales of multiple sclerosis therapies

Biogen revenue and profit shrink on Aduhelm costs, slumping sales of multiple sclerosis therapies

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A Biogen facility in Cambridge, Massachusetts. Brian Snyder | Reuters Biogen on Tuesday reported fourth-quarter revenue and profit that shrank from a year ago, as it recorded charges related to dropping its controversial Alzheimer’s drug Aduhelm and as sales slumped in its multiple sclerosis therapies, the company’s … Read more

Biogen drops controversial Alzheimer’s drug Aduhelm to focus on Leqembi, experimental treatments

Biogen drops controversial Alzheimer’s drug Aduhelm to focus on Leqembi, experimental treatments

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The Biogen headquarters in Cambridge, Massachusetts, on Tuesday, Oct. 24, 2023. Vanessa Leroy | Bloomberg | Getty Images Biogen on Wednesday said it will discontinue the sale and development of its older and highly controversial Alzheimer’s drug Aduhelm to refocus the company’s efforts to treat the … Read more

Why we like health-care stocks in 2024 despite their spotty record in presidential election years

Why we like health-care stocks in 2024 despite their spotty record in presidential election years

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE As the old Wall Street adage goes, health care tends to underperform the stock market in presidential election years — and in recent cycles, that’s been true. But, there’s reason to believe this year that many health-related stocks, led by Eli Lilly , could defy historical … Read more

Weight loss drugs, Alzheimer’s treatments and gene editing: Enormous firsts defined 2023 in pharma

Weight loss drugs, Alzheimer’s treatments and gene editing: Enormous firsts defined 2023 in pharma

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Soumyabrata Roy | Nurphoto | Getty Images Drugmakers are closing out a year when they achieved several historic firsts that will shape the pharmaceutical industry in 2024 and beyond.  The weight loss drug market transformed into the pharmaceutical industry’s newest gold rush this year, as demand … Read more

Pfizer’s twice-daily weight loss pill joins a long list of obesity drug flops

Pfizer’s twice-daily weight loss pill joins a long list of obesity drug flops

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Sopa Images | Lightrocket | Getty Images Pfizer’s twice-daily version of its experimental weight loss pill has now joined a long list of other scrapped drugs that aimed to treat obesity but came with unintended consequences.  The drugmaker on Friday said it will stop developing the … Read more

More convenient form of breakthrough Alzheimer’s drug Leqembi shows promising results in study

Healthy Returns: The launch of breakthrough Alzheimer’s drug Leqembi is off to a slow start

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Eisai on Wednesday said an injectable version of the Alzheimer’s drug Leqembi showed promising initial results in a clinical trial, potentially paving the way for a new and more convenient option for administering the antibody treatment.  However, the injection did not cause lower rates of brain … Read more

Eli Lilly expects an FDA decision on the Alzheimer’s treatment with donanemab by the end of the year

Eli Lilly expects an FDA decision on the Alzheimer’s treatment with donanemab by the end of the year

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Eli Lilly and Company, pharmaceutical company headquarters in Alcobendas, Madrid, Spain. Cristina Arias | Cover | Getty Images Eli Lilly said Monday that it has applied for full approval from the U.S. Food and Drug Administration for the treatment of Alzheimer’s disease, donanemaband expects the agency … Read more

Medicare will pay for Alzheimer’s drug Leqembi. What patients and doctors need to know

Medicare will pay for Alzheimer’s drug Leqembi.  What patients and doctors need to know

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The Alzheimer’s drug Leqembi is seen in this undated photo of a handout obtained by Reuters on January 20, 2023. Eisai | via Reuters Medicare agreed to pay for Alzheimer’s treatment Leqembia major turning point for patients diagnosed with early stages of the disease. Leqembi is … Read more

Sales of Alzheimer’s drug Leqembi may be slow at first but could pick up in 2024

Sales of Alzheimer’s drug Leqembi may be slow at first but could pick up in 2024

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Jay Reinstein, who suffers from Alzheimer’s disease, receives an injection so he can have a PET scan on June 20, 2023 at MedStar Georgetown University Hospital in Washington, DC. Michael Robinson Chávez | The Washington Post | Getty Images Sales on Alzheimer’s drug Leqembi may be … Read more

FDA approves Alzheimer’s drug Leqembi, paving the way for broader Medicare coverage

FDA approves Alzheimer’s drug Leqembi, paving the way for broader Medicare coverage

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The Food and Drug Administration on Thursday approved the Alzheimer’s drug Leqembi, a key decision that is expected to expand access to the expensive drug for older Americans. Medicare he promised to start covering Leqembi, under certain conditions, on the same day FDA approve antibody treatment. … Read more

FDA advisers to consider whether Alzheimer’s drug Leqembi should get full approval

FDA advisers to consider whether Alzheimer’s drug Leqembi should get full approval

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE [The stream is scheduled to begin at 10 a.m. ET. Please refresh the page if you don’t see a player above at that time.] A panel of independent advisers to the Food and Drug Administration is meeting Friday to make a recommendation on whether the Alzheimer’s … Read more

Bernie Sanders says cost of Alzheimer’s treatment unconscionable, urges HHS to act

Bernie Sanders says cost of Alzheimer’s treatment unconscionable, urges HHS to act

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Senator Bernie Sanders (I-VT) arrives at the US Capitol building on June 1, 2023 in Washington, DC. Anna Moneymaker | Getty Images Sen. Bernie Sanders on Wednesday called on the U.S. Department of Health and Human Services to take action to ensure that seniors can actually … Read more

Leqembi’s Alzheimer’s treatment could cost Medicare up to $5 billion a year, study estimates

Leqembi’s Alzheimer’s treatment could cost Medicare up to  billion a year, study estimates

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The Alzheimer’s drug LEQEMBI is seen in this undated photo of a handout obtained by Reuters on January 20, 2023. Eisai | Reuters New ones Alzheimer’s diseasetreatment with antibodies Leqembi could cost Medicare up to $5 billion a year research published this week in a leading … Read more

Bipartisan attorneys general urge Medicare to cover Alzheimer’s treatment

Bipartisan attorneys general urge Medicare to cover Alzheimer’s treatment

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The Alzheimer’s drug LEQEMBI is seen in this undated photo of a handout obtained by Reuters on January 20, 2023. Eisai | via Reuters Democratic and Republican attorneys general in nearly half of US states are urging Medicare to provide unlimited coverage for Alzheimer’s antibody treatment, … Read more

Alzheimer’s patients may wait years to get treated with new drugs, putting them at risk of more severe disease

Alzheimer’s patients may wait years to get treated with new drugs, putting them at risk of more severe disease

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Juanmonino | E+ | Getty Images Seniors with early Alzheimer’s disease will face major hurdles to get treated even if promising new drugs roll out more broadly in the coming years, putting them at risk of developing more severe disease as they wait months or perhaps … Read more

Alzheimer’s disease: Medicare will cover Leqembi for all patients if FDA approves drug, CMS chief says

Alzheimer’s disease: Medicare will cover Leqembi for all patients if FDA approves drug, CMS chief says

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Chiquita Brooks-LaSure testifies before the Senate Finance Committee on Thursday, April 15, 2021, during a hearing on her nomination to be the administrator of the Centers for Medicare & Medicaid Services in Washington. Caroline Brehman | CQ-Roll Call, Inc. | Getty Images Medicare will cover the … Read more

Biogen isn’t worried about competing with Eli Lilly on Alzheimer’s drugs, CEO says

Biogen isn’t worried about competing with Eli Lilly on Alzheimer’s drugs, CEO says

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A person skateboards past the headquarters of Biogen Inc. in Cambridge, Massachusetts on Monday, June 7, 2021. Adam Glanzman | Bloomberg | Getty Images Biogen not worried about competing with Eli Lilly because both are trying to bring on alzheimer’s disease medicine to the market, Biogen’s … Read more

Alzheimer’s patients retain the benefits of Leqembi even after they stop taking the drug, Eisai says

Alzheimer’s patients retain the benefits of Leqembi even after they stop taking the drug, Eisai says

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Research at Biogen Source: Biogen Alzheimer’s patients taking Leqembi maintain the benefits of treatment even after they stop taking it, new research the author Eisai shows. A Japanese drug manufacturer and its partner Biogen last week published an additional analysis of clinical trials a monoclonal antibody … Read more

Alzheimer’s patients retain the benefits of Leqembi even after they stop taking the drug, Eisai says

Alzheimer’s patients retain the benefits of Leqembi even after they stop taking the drug, Eisai says

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Research at Biogen Source: Biogen Alzheimer’s patients taking Leqembi maintain the benefits of treatment even after they stop taking it, new research the author Eisai shows. A Japanese drug manufacturer and its partner Biogen last week published an additional analysis of clinical trials a monoclonal antibody … Read more

Eli Lilly says experimental Alzheimer’s drug reduces brain plaque in early study

Eli Lilly says experimental Alzheimer’s drug reduces brain plaque in early study

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Medical bottles and syringes are seen with the Eli Lilly and company logo displayed on a screen in the background in this illustration photo taken in Krakow, Poland on November 10, 2022. Jakub Porzycki | Nurphoto | Getty Images Eli LillyAn experimental Alzheimer’s drug has reduced … Read more

Veterans Health will cover Leqembi Alzheimer’s treatment for some patients

Veterans Health will cover Leqembi Alzheimer’s treatment for some patients

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The Health Care Administration will take care Eisai and BiogenAlzheimer’s treatment Leqembi for some patients, the companies said Monday. In a statement, Eisai said veterans in the early stages of the disease who meet VHA criteria are eligible for Leqembi coverage. The company did not provide … Read more

The FDA will review Eisai and Biogen’s Alzheimer’s treatment Leqembi with a full approval decision expected in early July

The FDA will review Eisai and Biogen’s Alzheimer’s treatment Leqembi with a full approval decision expected in early July

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Andrew Brookes | Image Source | Getty Images The Food and Drug Administration will decide whether to give full approval Eisaiand BiogenAlzheimer’s treatment Leqembi by July 6, the companies said on Monday. Leqembi is an antibody treatment that targets the brain plaques associated with the mind-robbing … Read more

Medicare is rejecting the Alzheimer’s Association’s request for unlimited coverage of treatments like Leqembi

Medicare is rejecting the Alzheimer’s Association’s request for unlimited coverage of treatments like Leqembi

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Medicare will not provide broader coverage of the Alzheimer’s drug Leqembi until it receives more evidence that the treatment is reasonable and necessary, according to the federal agency that runs the program for the elderly. The Centers for Medicare and Medicaid Services has rejected the Alzheimer’s … Read more

Senators urge Medicare to offer broad coverage of Alzheimer’s disease treatment as public pressure mounts

Senators urge Medicare to offer broad coverage of Alzheimer’s disease treatment as public pressure mounts

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE US senators on Friday called on Medicare to offer broad coverage of Alzheimer’s treatments approved by the Food and Drug Administration, warning that current restrictions cost patients valuable time as their disease progresses. “Given the progressive nature of this terminal illness, we encourage you to take … Read more

Maker of promising Alzheimer’s drug Leqembi expects full FDA approval this summer, expanded Medicare coverage

Maker of promising Alzheimer’s drug Leqembi expects full FDA approval this summer, expanded Medicare coverage

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Tek Image/Science Photo Library | Scientific Photo Library | Getty Images Japanese drugmaker Eisai expects the Food and Drug Administration to fully approve its Alzheimer’s treatment Leqembi this summer, which would expand Medicare access to the expensive new antibody. US CEO Ivan Cheung said the FDA, … Read more

The FDA has approved an Alzheimer’s drug that slowed cognitive decline in a clinical trial

The FDA has approved an Alzheimer’s drug that slowed cognitive decline in a clinical trial

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE An MRI image of the brain showing the region of a patient with Alzheimer’s disease. Getty Images The Food and Drug Administration on Friday granted accelerated approval to the Alzheimer’s drug lekanemab, developed by Biogen and Japanese pharmaceutical company Eisai. The FDA approval came after clinical … Read more

Why Aduhelm for Alzheimer’s Biogen is so controversial

Why Aduhelm for Alzheimer’s Biogen is so controversial

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE US Food and Drug Administration approval BiogenAduhelm for Alzheimer’s was announced in June as a historic victory in the fight against a disease that kills thousands of Americans every year. But enthusiasm for the first FDA-approved drug to target the root cause of a memory-stealing disease … Read more

;
error: Content is protected !!